ROIV Free Cash Flow History: $-758.6M (FY2026)

Fiscal year	Q1	Q2	Q3	Q4
FY27	−$271M−30.0%	Not reported	Not reported	Not reported
FY26	−$208M−7.5%	−$194M+27.7%	−$201M+3.7%	−$165M+4.8%
FY25	−$194M+22.6%	−$268M−36.1%	−$209M+0.8%	−$173M−59.3%
FY24	−$250M+3.5%	−$197M−2.1%	−$211M+5.5%	−$109M+39.8%
FY23	−$260M−80.9%	−$193M−56.2%	−$223M+18.7%	−$181M−17.5%

01—History

Free Cash Flow History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2021–FY2026. Drag across the bars to change the range.

−$758.6M

YoY changeLargest recent move−24.6%in FY22Latest +10.1%

02—Ledger

Free Cash Flow, period by period

Period	Value	Change	Source
FY2026	−$758.6M	+10.1%	10-K
FY2025	−$844.0M	−10.1%	10-K
FY2024	−$766.6M	+10.4%	10-K
FY2023	−$856.1M	−23.1%	10-K
FY2022	−$695.2M	−24.6%	10-K
FY2021	−$557.9M	—	10-K

03—Questions

What is Roivant Sciences's current free cash flow?

Roivant Sciences (ROIV) annual free cash flow for 2026 was $-758.6M, a 10.13% increase from 2025. Roivant Sciences free cash flow for the quarter ending June 30, 2026 was $-270.9M.

What was Roivant Sciences's free cash flow in 2025?

Roivant Sciences annual free cash flow for 2025 was $-844.0M, a 10.10% decline from 2024.

What was Roivant Sciences's free cash flow in 2024?

Roivant Sciences annual free cash flow for 2024 was $-766.6M, a 10.45% increase from 2023.

Company: Roivant Sciences
Ticker: ROIV
Sector: Healthcare
Industry: Pharmaceutical Preparations

Roivant Sciences Free Cash Flow 2021-2027 | ROIV

Key Statistics